Tissue Regenix Group is a pioneering international medical technology company that focuses on the development of regenerative products. Their vision is to establish themselves as a leader in the science and innovation of regenerative medicine, committed to transforming patient care and delivering favorable health economic outcomes.
They utilize innovative platform technologies, such as dCELL and BioRinse, to address clinical needs in the regenerative medicine market. Tissue Regenix Group develops regenerative products in the fields of BioSurgery, Orthopaedics, and Dental, aiming to provide differentiated clinical outcomes and transform the treatment of patients.
Generated from the website